Stage Migration in Planning PET/CT Scans in Patients Due to Receive Radiotherapy for Non-Small-Cell Lung Cancer

被引:58
作者
Geiger, Geoffrey A. [1 ]
Kim, Miranda B. [1 ]
Xanthopoulos, Eric P. [1 ]
Pryma, Daniel A. [1 ]
Grover, Surbhi [1 ]
Plastaras, John P. [1 ]
Langer, Corey J. [1 ]
Simone, Charles B., II [1 ]
Rengan, Ramesh [1 ]
机构
[1] Univ Penn, Sch Med, Dept Radiat Oncol, Perelman Ctr Adv Med, Philadelphia, PA 19104 USA
关键词
Chemoradiotherapy; Disease progression; Locally advanced; Stage migration; Will Rogers; DISEASE PROGRESSION; TARGET VOLUMES; WAITING-TIMES; GROWTH; CANDIDATES; DIAGNOSIS; RATES; CT;
D O I
10.1016/j.cllc.2013.08.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Currently, controversy surrounds how long a delay is needed to affect the results of radiochemotherapy in patients with non-small-cell lung cancer. The present findings suggest that delays of just 6 weeks may degrade treatment efficacy. In 26% of the patients, TNM stage progression changed treatment intent after a repeat PET/CT scan taken, on median, 45 days after the initial scan. Introduction: This study examined rates of tumor progression in treatment-naive patients with non-small-cell lung cancer (NSCLC) as determined by repeat treatment-planning fluorine-18 (F-18) fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT). Methods and Materials: This study assessed patients who underwent PET/CT simulation for NSCLC stage II/III, radiation-naive, nonmetastatic NSCLC. It compared planning PET/CT with previous PET/CT images. Patients were analyzed for change in stage, treatment intent, or both. Progression was defined as a change in TNM status leading to upstaging, and standardized uptake value (SUV) velocity was defined as [(SUVscan2 - SUVscan1)/interscan interval in days]. Results: Of 149 consecutive patients examined between April 2009 and April 2011, 47 had prior PET/CT scans and were included. The median age was 68 years. New nodal disease or metastatic disease was identified in 24 (51%) of 47 patients. Fourteen (30%) had evidence of extrathoracic metastatic disease; the remaining 10 (21%) had new nodal disease that required substantial alteration of treatment fields. At a scan interval of 20 days, the rate of upstaging was 17%. SUV velocity was analyzed in the subset of patients who had their studies on the identical PET/CT scanner (n = 14). Nonupstaged patients had a mean SUV velocity of 0.074 units per day, compared with 0.11 units per day in patients that were upstaged by their second PET/CT scan (P = .020). Conclusion: Radiation treatment planning with hybrid PET/CT scans repeated within 120 days of an initial staging PET/CT scan identified significant upstaging in more than half of patients. For a subset of patients who underwent both scans on the same instrument, SUV velocity predicts upstaging, and the difference between those upstaged and those not was statistically significant. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:79 / 85
页数:7
相关论文
共 22 条
[1]  
[Anonymous], 2014, United States Cancer Statistics: 1999-2010 Incidence and Mortality Web-based Report
[2]  
[Anonymous], J NUCL MED TECHNOL
[3]   Time in radiation oncology - Keep it short! [J].
Buetof, Rebecca ;
Baumann, Michael .
RADIOTHERAPY AND ONCOLOGY, 2013, 106 (03) :271-275
[4]   The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature [J].
Chen, Zheng ;
King, Will ;
Pearcey, Robert ;
Kerba, Marc ;
Mackillop, William J. .
RADIOTHERAPY AND ONCOLOGY, 2008, 87 (01) :3-16
[5]   Quantification of progression of non-small cell lung cancer in the interval between diagnostic and radiotherapy treatment planning PET scans [J].
Eastham, D. V. ;
Weerasuriya, D. ;
Wakelee, H. ;
Quon, A. ;
Maxim, P. ;
Le, Q. ;
Graves, E. E. ;
Loo, B. W. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03) :S520-S521
[6]   The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer [J].
Everitt, Sarah ;
Plumridge, Nikki ;
Herschtal, Alan ;
Bressel, Mathias ;
Ball, David ;
Callahan, Jason ;
Kron, Tomas ;
Schneider-Kolsky, Michal ;
Binns, David ;
Hicks, Rodney J. ;
Mac Manus, Michael .
RADIOTHERAPY AND ONCOLOGY, 2013, 106 (03) :288-291
[7]   High Rates of Tumor Growth and Disease Progression Detected on Serial Pretreatment Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Scans in Radical Radiotherapy Candidates With Nonsmall Cell Lung Cancer [J].
Everitt, Sarah ;
Herschtal, Alan ;
Callahan, Jason ;
Plumridge, Nikki ;
Ball, David ;
Kron, Tomas ;
Schneider-Kolsky, Michal ;
Binns, David ;
Hicks, Rodney J. ;
MacManus, Michael .
CANCER, 2010, 116 (21) :5030-5037
[8]   Use of combined PET/CT images for radiotherapy planning: initial experiences in lung cancer [J].
Jarritt, PH ;
Hounsell, AR ;
Carson, KJ ;
Visvikis, D ;
Cosgrove, VP ;
Clarke, JC ;
Stewart, DP ;
Fleming, VAL ;
Eakin, RL ;
Zatari, A .
BRITISH JOURNAL OF RADIOLOGY, 2005, 78 :33-40
[9]   Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements [J].
Jennings, S. Gregory ;
Winer-Muram, Helen T. ;
Tann, Mark ;
Ying, Jun ;
Dowdeswell, Ian .
RADIOLOGY, 2006, 241 (02) :554-563
[10]   Staging of Non-Small Cell Lung Cancer Using Integrated PET/CT [J].
Kligerman, Seth ;
Digumarthy, Subba .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (05) :1203-1211